Market Overview

More Headlines

public domain
Jim Lebenthal said on CNBC's Fast Money Halftime Report that he is a buyer of Apple Inc. (NASDAQ: AAPL). He likes...
public domain
Recode's Kara Swisher and The Verge's Lauren Goode took a look back at what they consider to be the top 10...
public domain
The Dow Jones Industrial Average have been on a tear in 2016, advancing 13.74 percent. This came after a 2.23 percent...
Public Domain
Every trader knows that predicting financial markets can be a humbling experience. After offering some boldly bearish...
Public Domain
Since reports of Kate Spade & Co (NYSE: KATE) exploring sale emerged, the market is abuzz with speculations over...
Public Domain
Ronnie Moas of Standpoint Research defends Opko Health Inc. (NASDAQ: OPK), whose shares plunged more than 18 percent...
Public Domain
Crude oil is on pace to finish 2016 near a multi-year high, which marks a reversal from 2015 when the commodity ended...
Public Domain
Shares of Apple Inc. (NASDAQ: AAPL) were trading lower by nearly 1 percent on Friday following a concerning report...
Public Domain
Argus analysts reiterated a Buy rating on Xilinx, Inc. (NASDAQ: XLNX) and raised the price target by $10. Xilinx, a...
Public Domain
Traders got a small taste of the dangerous short squeeze potential that Fitbit Inc (NYSE: FIT) has this week when the...
Public Domain
Here is a look at some of the largest declining biotech names during the final week of 2016. Anthera Anthera...
Public Domain
Emerging markets debt exchange traded funds were supposed to be vulnerable in the face of the Federal Reserve's...
Public Domain
Shares of Opko Health Inc. (NASDAQ: OPK), a pharmaceutical and diagnostics company, plunged more than 15 percent on...
Public Domain
Thousands of digital items are now on sale on Amazon.com. Amazon.com, Inc. (NASDAQ: AMZN) is hosting its first-ever...
Public Domain
Shares of Cabelas Inc (NYSE: CAB) plunged more than 5.5 percent on concerns that its merger with Bass Pro Shops would...
Public Domain
Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses...
Public Domain
It's an open secret that Virtual Reality would be one of the central themes of 2017

You Might Have Missed...